arrow
A

Anna Tosi

istituto oncologico veneto iov irccs
H指数:16
被引数:890

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting peptidyl-arginine deiminase 4 suppresses SARS-CoV-2 replication and modulates the inflammatory response

靶向肽基精氨酸脱亚胺酶4可抑制SARS-CoV-2复制并调节炎症反应

2026-02-170
OAAI
Basal-like HR + /HER2- breast cancers show higher tumor-infiltrating lymphocytes and immune signatures with potential therapeutic implications

Basal-like HR⁺/HER2⁻乳腺癌显示出更高的肿瘤浸润淋巴细胞和免疫特征,具有潜在的治疗意义。

2025-12-240
OAAI
Microbiome modulation uncouples efficacy and toxicity induced by immune checkpoint blockade in mouse multiple myeloma

微生物组调控可解耦小鼠多发性骨髓瘤中免疫检查点阻断所诱导的疗效与毒性

2025-11-240
OAAI
On the adjuvanticity of hyaluronan: The case of a SARS-CoV-2 vaccine

透明质酸的佐剂特性:以SARS-CoV-2疫苗为例

2025-06-010
OAAI
Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma

2型转谷氨酰胺酶mitf轴调节皮肤皮肤黑素瘤的表型转换

2023-10-283
OAAI
Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells
2023-03-189
OAAI
Case report: Complete pathologic response with first-line immunotherapy combination in a young adult with massive liver dissemination of mismatch repair-deficient metastatic colorectal cancer: Immunological and molecular profiling
2022-12-081
OAAI
The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naive tumors with immune checkpoint inhibitors
2022-09-2036
OAAI
Reduced Interleukin-17-Expressing Cells in Cutaneous Melanoma
2021-12-163
OAAI
Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA Trial
2021-10-1954
OAAI